Expression of the ribosomal proteins Rplp0, Rplp1, and Rplp2 in gynecologic tumors

Boisvert, 2007, The multifunctional nucleolus, Nat Rev Mol Cell Biol, 8, 574, 10.1038/nrm2184 Ishii, 2006, Characteristics and clustering of human ribosomal protein genes, BMC Genomics, 7, 37, 10.1186/1471-2164-7-37 Uechi, 2001, A complete map of the human ribosomal protein genes: assignment of 80 genes to the cytogenetic map and implications for human disorders, Genomics, 72, 223, 10.1006/geno.2000.6470 Naora, 1999, Involvement of ribosomal proteins in regulating cell growth and apoptosis: translational modulation or recruitment for extraribosomal activity?, Immunol Cell Biol, 77, 197, 10.1046/j.1440-1711.1999.00816.x Jin, 2004, Inhibition of HDM2 and activation of p53 by ribosomal protein L23, Mol Cell Biol, 24, 7669, 10.1128/MCB.24.17.7669-7680.2004 Wool, 1996, Extraribosomal functions of ribosomal proteins, Trends Biochem Sci, 21, 164, 10.1016/0968-0004(96)20011-8 Lindstrom, 2008, Ribosomal protein S9 is a novel B23/NPM-binding protein required for normal cell proliferation, J Biol Chem, 283, 15568, 10.1074/jbc.M801151200 Takagi, 2005, Regulation of p53 translation and induction after DNA damage by ribosomal protein L26 and nucleolin, Cell, 123, 49, 10.1016/j.cell.2005.07.034 Zhang, 2006, Ribosomal stress couples the unfolded protein response to p53-dependent cell cycle arrest, J Biol Chem, 281, 30036, 10.1074/jbc.M604674200 Ruggero, 2003, Does the ribosome translate cancer?, Nat Rev Cancer, 3, 179, 10.1038/nrc1015 Castro, 2008, Loss-of-function genetic screening identifies a cluster of ribosomal proteins regulating p53 function, Carcinogenesis, 29, 1343, 10.1093/carcin/bgm302 Farrar, 2008, Abnormalities of the large ribosomal subunit protein, Rpl35a, in Diamond-Blackfan anemia, Blood, 112, 1582, 10.1182/blood-2008-02-140012 Gazda, 2008, Ribosomal protein L5 and l11 mutations are associated with cleft palate and abnormal thumbs in Diamond-Blackfan anemia patients, Am J Hum Genet, 83, 769, 10.1016/j.ajhg.2008.11.004 Bortoluzzi, 2001, Differential expression of genes coding for ribosomal proteins in different human tissues, Bioinformatics, 17, 1152, 10.1093/bioinformatics/17.12.1152 Wang, 2006, Overexpression of ribosomal protein L15 is associated with cell proliferation in gastric cancer, BMC Cancer, 6, 91, 10.1186/1471-2407-6-91 Barnard, 1992, Increased expression of human ribosomal phosphoprotein P0 messenger RNA in hepatocellular carcinoma and colon carcinoma, Cancer Res, 52, 3067 Pogue-Geile, 1991, Ribosomal protein genes are overexpressed in colorectal cancer: isolation of a cDNA clone encoding the human S3 ribosomal protein, Mol Cell Biol, 11, 3842, 10.1128/MCB.11.8.3842 Barnard, 1993, Gastric and hepatocellular carcinomas do not overexpress the same ribosomal protein messenger RNAs as colonic carcinoma, Cancer Res, 53, 4048 Lai, 2007, Ribosomal proteins and colorectal cancer, Curr Genomics, 8, 43, 10.2174/138920207780076938 Artero-Castro, 2009, Rplp1 bypasses replicative senescence and contributes to transformation, Exp Cell Res, 315, 1372, 10.1016/j.yexcr.2009.02.007 Tchorzewski, 2002, The acidic ribosomal P proteins, Int J Biochem Cell Biol, 34, 911, 10.1016/S1357-2725(02)00012-2 Elkon, 1985, Lupus autoantibodies target ribosomal P proteins, J Exp Med, 162, 459, 10.1084/jem.162.2.459 Rayno, 2000, Evaluation of assays for the detection of autoantibodies to the ribosomal P proteins, Clin Immunol, 95, 99, 10.1006/clim.2000.4852 Martinez-Azorin, 2008, Functional characterization of ribosomal P1/P2 proteins in human cells, Biochem J, 413, 527, 10.1042/BJ20080049 Chen, 2002, Two forms of gonadotropin-releasing hormone (GnRH) are expressed in human breast tissue and overexpressed in breast cancer: a putative mechanism for the antiproliferative effect of GnRH by down-regulation of acidic ribosomal phosphoproteins P1 and P2, Cancer Res, 62, 1036 Zhang, 1997, Gene expression profiles in normal and cancer cells, Science, 276, 1268, 10.1126/science.276.5316.1268 Jemal, 2009, Cancer statistics, 2009, CA Cancer J Clin, 59, 225, 10.3322/caac.20006 Mariani, 2002, Surgical stage I endometrial cancer: predictors of distant failure and death, Gynecol Oncol, 87, 274, 10.1006/gyno.2002.6836 Cannistra, 2004, Cancer of the ovary, N Engl J Med, 351, 2519, 10.1056/NEJMra041842 Rimm, 2001, Amplification of tissue by construction of tissue microarrays, Exp Mol Pathol, 70, 255, 10.1006/exmp.2001.2363 Scheres, 1988, Quantification of oestrogen receptors in breast cancer: radiochemical assay on cytosols and cryostat sections compared with semiquantitative immunocytochemical analysis, J Clin Pathol, 41, 623, 10.1136/jcp.41.6.623 Hollstein, 1991, p53 mutations in human cancers, Science, 253, 49, 10.1126/science.1905840 Loging, 1999, Elevated expression of ribosomal protein genes L37, RPP-1, and S2 in the presence of mutant p53, Cancer Epidemiol Biomarkers Prev, 8, 1011 Kamata, 2007, Mutation of the p53 tumour suppressor gene and overexpression of its protein in 62 Japanese non-Hodgkin's lymphomas, Clin Exp Med, 7, 39, 10.1007/s10238-007-0124-0 Welsh, 2001, Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer, Proc Natl Acad Sci U S A, 98, 1176, 10.1073/pnas.98.3.1176 Sharp, 1990, Sequence previously identified as metastasis-related encodes an acidic ribosomal phosphoprotein, P2, Br J Cancer, 61, 83, 10.1038/bjc.1990.19 Lax, 2000, The frequency of p53, K-ras mutations, and microsatellite instability differs in uterine endometrioid and serous carcinoma: evidence of distinct molecular genetic pathways, Cancer, 88, 814, 10.1002/(SICI)1097-0142(20000215)88:4<814::AID-CNCR12>3.0.CO;2-U Ueno, 2006, Prognostic significance of p53 mutation in suboptimally resected advanced ovarian carcinoma treated with the combination chemotherapy of paclitaxel and carboplatin, Cancer Lett, 241, 289, 10.1016/j.canlet.2005.10.035 Darcy, 2008, Associations between p53 overexpression and multiple measures of clinical outcome in high-risk, early stage or suboptimally-resected, advanced stage epithelial ovarian cancers. A Gynecologic Oncology Group study, Gynecol Oncol, 111, 487, 10.1016/j.ygyno.2008.08.020 Bossi, 2006, Mutant p53 gain of function: reduction of tumor malignancy of human cancer cell lines through abrogation of mutant p53 expression, Oncogene, 25, 304, 10.1038/sj.onc.1209026